Abstract
RGD-containing substrates were used to study static and hydrodynamic adhesion of murine RAW117 large-cell lymphoma sublines with differential liver-metastatic potentials. Highly liver-metastatic RAW117-H10 cells had higher rates of static adhesion to vitronectin, fibronectin and (GRGDS) than poorly metastatic RAW117-P and moderately liver-metastatic RAW117-L17 cells. Under hydrodynamic conditions, adhesion stabilization was more rapid for H10 cells compared to P or L17 cells. Among the RGD peptides, only the polymeric RGD peptide (GRGDS) mediated strong static adhesion of H10 cells. Interestingly, all the RGD peptides mediated adhesion stabilization for H10 cells but still not for L17 or P cells under hydrodynamic conditions. Integrin αβ was involved in stabilizing hydrodynamic adhesion to (GRGDS), monomeric RGD peptide R1, but was less important in static adhesion to monomeric RGD peptides. Differential adhesion to liver sinusoidal endothelial cell-derived extracellular matrix (H10 ≫ L17 > P) was observed under hydrodynamic but not static conditions. Integrin αβ was also important in hydrodynamic adhesion to liver sinusoidal endothelial cell-derived extracellular matrix. We believe that strong static and hydrodynamic adhesion of H10 cells and their capability of altering adhesive behavior in response to fluid shear may contribute to liver metastasis.
Similar content being viewed by others
References
Nicolson GL, 1989, Metastatic tumor cell interactions with endothelium, basement membrane and tissue. Curr Opin Cell Biol, 1, 1009–19.
Nicolson GL, 1988, Organ specificity of tumor metastasis: role of preferential adhesion, invasion and growth of malignant cells at specific secondary sites. Cancer Metastasis Rev, 7, 143–88.
Liotta LA, Rao CN and Wewer UM, 1986, Biochemical interactions of tumor cells with the basement membrane. Ann Rev Biochem, 55, 1037–57.
Hynes RO, 1992, Integrins: versatility, modulation, and signaling in cell adhesion. Cell, 69, 11–25.
Ruoslahti E and Pierschbacher MD, 1987, New perspective in cell adhesion: RGD and integrins. Science, 238, 491–7.
Sheppard D, Rozzo C, Starr L, Quaranta V, Erle BJ and Pytela R, 1990, Complete amino acid sequence of a novel integrin b subunit (β6) identified in epithelial cells using the polymerase chain reaction. J Biol Chem, 265, 11502–7.
Ballantyne CM, O'Brien WE and Beaudet AL, 1989, Nucleotide sequence of the cDNA for murine intercellular adhesion molecule-1 (ICAM-1). Nucleic Acids Res, 17, 5853.
Bierer BE and Burakoff SJ, 1988, T cells adhesion molecules. FASEB J, 2, 2584–90.
Elices MJ, Urry LA and Hemler ME, 1991, Receptor functions for the integrin VLA-3: fibronectin, collagen, and laminin binding are differentially influenced by Arg-Gly-Asp peptide and by divalent cations. J Cell Biol, 112, 169–81.
Hautanen A, Gailit, J, Mann DM and Ruoslahti E, 1989, Effects of modifications of the RGD sequence and its context on recognition by the fibronectin receptor. J Biol Chem, 264, 1437–42.
Pierschbacher MD and Ruoslahti E, 1987, Influence of stereochemistry of the sequence Arg-Gly-Asp-Xaa on binding specificity in cell adhesion. J Biol Chem, 262, 17294–8.
Mortarini R and Anichini A, 1993, From adhesion to signaling: role of integrins in the biology of human melanoma. Melanoma Res, 3, 87–97.
Liesveld JL, Winslow JM, Frediani KE, Ryan DH and Abboud CN, 1993, Expression of integrins and examination of their adhesive function in normal and leukemic hematopoietic cells. Blood, 81, 112–21.
Dedhar S and Saulnier R, 1990, Alterations in integrin receptors on chemically transformed human cells: specific enhancement of laminin and collagen receptor complexes. J Cell Biol, 110, 481–9.
Plantefaber LC and Hynes RO, 1989, Changes in integrin receptor expression on oncogenically transformed cells. Cell, 56, 281–90.
McGregor BC, McGregor JL, Weiss LM, et al. 1989, Presence of cytoadhesins (IIb-IIIa-like glycoproteins) on human metastatic melanomas but not on benign melanocytes. Am J Clin Pathol, 92, 495–9.
Isoai A, Ueno Y, Giga-Hama Y, Goto H and Kumagai H, 1992}, A novel Arg-Gly-Asp containing peptide specific for platelet aggregation and its effect on tumor metastasis: a possible mechanism of RGD peptidemediated inhibition of tumor metastasis. Cancer Lett, 65, 259–64.
Sozka T, Knudsen KA, Beviglia L, Rossi C, Poggi A and Niewiarowski S, 1991}, Inhibition of murine melanoma cell-matrix adhesion and experimental metastasis by albolabrin, an RGD-containing peptide isolated from the venom of Trimeresurus albolabris. Exp Cell Res, 196, 6–12.
Saiki I, Iida, J, Murata J, et al. 1989, Inhibition of the metastasis of murine malignant melanoma by synthetic polymeric peptides containing core sequences of celladhesive molecules. Cancer Res, 49, 3815–22.
Humphries MJ, Olden K and Yamada KM, 1986, A synthetic peptide from fibronectin inhibits experimental metastasis of murine melanoma cells. Science, 233, 467–70.
Kramer RH, Enenstein J, Ramos DM, Vu MP and Cheng YF, 1991, The role of integrin receptors in tumor cell adhesion to the microvasculature. In: Orr FW, Buchanan MR and Weiss L, eds. Microcirculation in Cancer Metastasis. Boca Raton: CRC Press, Inc., pp. 145–68.
Smith TW, Yun Z, Menter DG, McIntire LV and Nicolson GL, 1996, Computer analysis of tumor cell interaction with extracellular matrix proteins and endothelial cells under laminar flow. Biotechnol Bioeng, 50, 598–607.
Patton JT, Menter DG, Benson DM, Nicolson GL and McIntire LV, 1993, Computer analysis of tumor cells flowing in a parallel plate flow chamber to determine their adhesion stabilization lag time. Cell Motility Cytoskeleton, 26, 88–98.
Menter DG, Patton JT, UpDyke TV, et al. 1992, Transglutaminase stabilizes melanoma adhesion under laminar flow. Cell Physics, 18, 123–43.
Brunson KW and Nicolson GL, 1978, Selection and biological properties of malignant variants of a murine lymphosarcoma. J Natl Cancer Inst, 61, 1499–503.
Yun Z, Menter DG and Nicolson GL, 1996, Involvement of integrin αvβ3 in adhesion and liver metastasis of murine RAW117 large-cell lymphoma cells. Cancer Res, 56, 3103–3111.
Gan ZR, Gould RJ, Jacobs JW, Friedman PA and Polokoff MA, 1988, Echistatin. A potent platelet aggregation inhibitor from the venom of the viper, Echis carinatus. J Biol Chem, 263, 19827–32.
Scarborough RM, Rose JW, Hsu MA, et al. 1991, A GPIIb-IIIa-specific integrin antagonist from the venom of Sistrurus m. barbouri. J Biol Chem, 266, 9359–62.
Brockel C, Cowley DJ and Pelton JT, 1992, Conformational studies of the 'RGD' containing peptide echistatin and close analogs by circular dichroism and fluorescence. Biochim Biophys Acta, 1122, 196–202.
Tressler RJ, Belloni PN and Nicolson GL, 1989, Correlation of inhibition of adhesion of large-cell lymphoma and hepatic sinusoidal endothelial cells by RGD-containing peptide polymers with metastatic potential: role of integrin-dependent and-independent adhesion mechanisms. Cancer Commun, 1, 55–63.
Belloni PN and Nicolson GL, 1988, Differential expression of cell surface glycoproteins on various organ-derived microvascular endothelia and endothelial cells cultures. J Cell Physiol, 136, 398–410.
Nicolson GL, Belloni PN, Tressler RJ, Dulski K, Inoue T and Cavanaugh PG, 1989, Adhesive, invasive, and growth properties of selected metastatic variants of a murine large-cell lymphoma. Invasion Metastasis, 9, 102–16.
Kramer RH and Nicolson GL, 1979, Interactions of tumor cells with vascular endothelial cell monolayers: a model for metastatic invasion. Proc Natl Acad Sci USA, 76, 5704–8.
Ruoslahti E and Giancotti FG, 1989, Integrins and tumor cell dissemination. Cancer Cells, 1, 119–26.
Maher JJ and Bissell DM, 1993, Cell-matrix interactions in liver. Seminars Cell Biol, 4, 189–201.
Preissner KT, 1991, Structure and biological role of vitronectin. Ann Rev Cell Biol, 7, 275–310.
Oh E, Pierschbacher MD and Ruoslahti E, 1981, Deposition of plasma fibronectin in tissues. Proc Natl Acad Sci USA, 78, 3218–21.
Hamann A and Rebstock S, 1993, Migration of activated lymphocytes. Curr Topics Microbiol Immunol, 183, 109–25.
Stupack DG, Shen C and Wilkins JA, 1992, Induction of αvβ3 integrin-mediated attachment to extracellular matrix in β1 integrin (CD29)-negative B cell lines. Exp Cell Res, 203, 443–8.
Ballard LL, Brown EJ and Holers VM, 1991, Expression of the fibronectin receptor VLA-5 is regulated during human B cell differentiation and activation. Clin Exp Immunol, 84, 336–46.
Moulder K, Roberts K, Shevach EM and Coligan JE, 1991, The mouse vitronectin receptor is a T cell activation antigen. J Exp Med, 173, 343–7.
Ruoslahti E, 1991, Integrins. J Clin Invest, 87, 1–5.
Kojima N, Handa K, Newman W and Hakomori S, 1992, Multi-recognition capability of E-selectin in a dynamic flow system, as evidenced by differential effects of sialidase and anti-carbohydrate antibodies on selectin-mediated cell adhesion at low vs. high shear stress: a preliminary note. Biochem Biophys Res Commun, 189, 1686–94.
Olesen SP, Clapham DE and McIntire LV, 1983, Haemodynamic shear stress activates a K+ current in vascular endothelial cells. Nature, 331, 168–70.
Geiger RV, Berk BC, Alexander RW and Nerem RM, dy{1992}, Flow-induced calcium transients in single endothelial cells: spatial and temporal analysis. Am J Physiol, 262, C1411-7.
Kroll MH, Hellums JD, Guo Z, et al. 1993, Protein kinase C is activated in platelets subjected to pathological shear stress. J Biol Chem, 256, 3520–4.
Razdan K, Hellums JD and Kroll MH, 1994, Shearstress-induced von Willebrand factor binding to platelets causes the activation of tyrosine kinases. Biochem J, 302, 681–6.
Morigi M, Zoja C, Figliuzzi M, et al. 1995, Fluid shear stress modulates surface expression of adhesion molecules by endothelial cells. Blood, 85, 1696–703.
Ando J, Tsuboi H, Korenaga R, et al. 1995, Downregulation of vascular adhesion molecule-1 by fluid shear stress in cultured mouse endothelial cells. Ann NY Acad Sci, 748, 148–56.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Yun, Z., Smith, T.W., Menter, D.G. et al. Differential adhesion of metastatic RAW117 large-cell lymphoma cells under static or hydrodynamic conditions: role of integrin alpha v beta3. Clin Exp Metastasis 15, 3–11 (1997). https://doi.org/10.1023/A:1018451616309
Issue Date:
DOI: https://doi.org/10.1023/A:1018451616309